RLMD — Relmada Therapeutics, Inc. | XLV Holdings | StockAdder

(RLMD)

Relmada Therapeutics, Inc.

Live chart and latest RLMD stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

RLMD News

Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?

Apr 13, 2026 Stock Titan

[EFFECT] RELMADA THERAPEUTICS, INC. SEC Filing

Apr 10, 2026 MSN

Relmada Therapeutics (RLMD) price target increased by 59.26% to 14.62

Apr 14, 2026 Eastern Progress

RLMD Stock Surges 42% in a Week: Here's What You Should Know

Apr 2, 2026 Seeking Alpha

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

Mar 30, 2026 Investing.com

Relmada Therapeutics stock surges 25% on bladder cancer data

Mar 9, 2026 TradingView — Track All Markets

Relmada Therapeutics Raises $160 Million in Private Placement of Stock and Pre-Funded Warrants

Mar 9, 2026 TipRanks

Why Is Relmada Therapeutics Stock (RLMD) Up Today?

Mar 9, 2026 Yahoo Finance

Here’s What Makes Mizuho Bullish on Relmada Therapeutics Inc (RLMD) Stock

Mar 24, 2026 Stock Titan

Relmada Therapeutics (NASDAQ: RLMD) registers 33.7M shares for resale under 424B3

Apr 9, 2026 Seeking Alpha

Relmada stock wins bullish view at Piper Sandler (RLMD:NASDAQ)

Mar 24, 2026 Yahoo Finance

Wall Street Analysts Predict a 92.19% Upside in Relmada Therapeutics (RLMD): Here's What You Should Know

Mar 26, 2026 Stock Titan

Biotech Relmada secures $160M private raise for drug R&D and operations

Mar 9, 2026 Yahoo Finance

Relmada Therapeutics, Inc. (RLMD) Advances Oncology and CNS Therapies with Promising Phase 2 Data

Sep 23, 2025 Stock Titan

Relmada Therapeutics (NASDAQ: RLMD) registers 33.7M shares for resale from $160M placement